Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Preferred Stock Liabilities (2019)

Historic Preferred Stock Liabilities for Pliant Therapeutics (PLRX) over the last 1 years, with Q4 2019 value amounting to $186.3 million.

  • Pliant Therapeutics' Preferred Stock Liabilities changed N/A to $186.3 million in Q4 2019 from the same period last year, while for Dec 2019 it was $186.3 million, marking a year-over-year change of. This contributed to the annual value of $186.3 million for FY2019, which is N/A changed from last year.
  • Pliant Therapeutics' Preferred Stock Liabilities amounted to $186.3 million in Q4 2019.
  • In the past 5 years, Pliant Therapeutics' Preferred Stock Liabilities ranged from a high of $186.3 million in Q4 2019 and a low of $186.3 million during Q4 2019